10-K/A: INVO Bioscience Files Amended Annual Report to Include Updated Auditor Consent

INVO Bioscience has filed an amendment to its annual report to include an updated consent from its independent auditor and certifications from its principal executive and financial officers.

Summary

• INVO Bioscience has filed Amendment No. 2 to its Form 10-K for the fiscal year ended December 31, 2022.
• This amendment includes an updated consent from M&K CPAs PLLC, the company's independent auditor.
• The auditor's consent is related to the incorporation of their report in previously filed registration statements.
• The report includes an explanatory paragraph regarding the company's ability to continue as a going concern.
• The amendment also includes certifications from the Principal Executive Officer and Principal Financial Officer.
• No other changes were made to the original filing or the first amendment.

Sentiment

Score: 5

Explanation: The document is primarily a compliance filing, but the inclusion of a going concern paragraph in the auditor's report introduces a note of caution.

Positives

• The company has taken steps to ensure compliance with SEC regulations by filing the necessary amendments.
• The updated auditor consent allows for the continued use of their report in registration statements.

Negatives

• The auditor's report includes an explanatory paragraph regarding the company's ability to continue as a going concern, which is a potential concern.

Risks

• The inclusion of a going concern paragraph in the auditor's report indicates potential financial instability.
• The company's ability to continue as a going concern is uncertain.

Management Comments

• Steven Shum, Chief Executive Officer, certified the report.
• Andrea Goren, Chief Financial Officer, certified the report.

Industry Context

This filing is a standard regulatory requirement for publicly traded companies, ensuring transparency and compliance with SEC regulations.

Comparison to Industry Standards

• The filing of an amended 10-K to include updated auditor consent is a common practice when there are changes or updates required after the initial filing.
• The inclusion of a going concern paragraph is not uncommon for companies facing financial challenges, but it is a point of concern for investors.
• The company's market capitalization of approximately $7.7 million is relatively small compared to larger biotech companies.

Stakeholder Impact

• Shareholders should be aware of the going concern paragraph in the auditor's report.
• The updated auditor consent ensures the company's financial statements are properly audited.

Key Dates

Keywords

INVO Bioscience, Form 10-K/A, Amendment, Auditor Consent, M&K CPAs PLLC, Going Concern, SEC Filing, Financial Statements, Registration Statements, Sarbanes-Oxley Act